| Nov-2021 | Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) | Sun, Hui-Chuan; Zhou, Jian; Wang, Zheng; Liu, Xiufeng; Xie, Qing; Jia, Weidong; Zhao, Ming; Bi, Xinyu; Li, Gong; Bai, Xueli; Ji, Yuan; Xu, Li; Zhu, Xiao-Dong; Bai, Dousheng; Chen, Yajin; Chen, Yongjun; Dai, Chaoliu; Guo, Rongping; Guo, Wenzhi; Hao, Chunyi; Huang, Tao; Huang, Zhiyong; Li, Deyu; Li, Gang; Li, Tao; Li, Xiangcheng; Liang, Xiao; Liu, Jingfeng; Liu, Fubao; Lu, Shichun; Lu, Zheng; Lv, Weifu; Mao, Yilei; Shao, Guoliang; Shi, Yinghong; Song, Tianqiang; Tan, Guang; Tang, Yunqiang; Tao, Kaishan; Wan, Chidan; Wang, Guangyi; Wang, Lu; Wang, Shunxiang; Wen, Tianfu; Xing, Baocai; Xiang, Bangde; Yan, Sheng; Yang, Dinghua; Yin, Guowen; Yin, Tao; Yin, Zhenyu; Yu, Zhengping; Zhang, Bixiang; Zhang, Jialin; Zhang, Shuijun; Zhang, Ti; Zhang, Yamin; Zhang, Yubao; Zhang, Aibin; Zhao, Haitao; Zhou, Ledu; Zhang, Wu; Zhu, Zhenyu; Qin, Shukui; Shen, Feng; Cai, Xiujun; Teng, Gaojun; Cai, Jianqiang; Chen, Minshan; Li, Qiang; Liu, Lianxin; Wang, Weilin; Liang, Tingbo; Dong, Jiahong; Chen, Xiaoping; Wang, Xuehao; Zheng, Shusen; Fan, Jia |
